August 22, 2016 / 10:22 AM / a year ago

BRIEF-Valeant appoints Paul Herendeen as chief financial officer

Aug 22 (Reuters) - Valeant Pharmaceuticals International Inc :

* Valeant pharmaceuticals appoints Paul S. Herendeen as executive vice president, finance and chief financial officer

* Herendeen will take over role of chief financial officer from Robert L. Rosiello effective immediately

* Prior to joining Valeant, Herendeen served as executive vice president and chief financial officer of Zoetis Inc. For two years

* Rosiello will assume responsibility for corporate development and strategy and continues as evp and an executive committee member Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below